Reckitt Benckiser Group (RKT)

Sector:

Household Goods

Index:

FTSE 100

4,859.00p
   
  • Change Today:
      26.00p
  • 52 Week High: 5,872.00p
  • 52 Week Low: 4,093.00p
  • Currency: UK Pounds
  • Shares Issued: 686.62m
  • Volume: 469,238
  • Market Cap: £33,363m

Sector movers: Defensives gain on mixed day, investors gird for BoE, Big Tech

By Alexander Bueso

Date: Monday 29 Jul 2024

LONDON (ShareCast) - (Sharecast News) - FTSE 350 stocks trade mixed at the start of the week with Defensive issues on the rise whilst geopolitics and concerns around economic growth overseas weighed on Travel and Personal Goods.
"Last week saw the FTSE 100 come storming back, as the index touched a three-month low and neared an almost two-month high in the space of 48 hours," was the explanation out of Chris Beauchamp, chief equity strategist at IG.

"UK investors, like everyone around the globe this week, will be trying to keep on top of the plethora of earnings and economic events, so it's not surprising that the index has struggled to maintain momentum in today's session."

The Bank of Japan and US Federal were to announce their latest policy decisions on Wednesday, followed by the Bank of England the next day.

Microsoft meanwhile would publish its quarterly results on Tuesday, followed by Meta, on Wednesday, and by Amazon and Apple on Thursday.

Travel and Leisure names came under selling pressure on Monday, due to concerns regarding the potential for a broader conflict in the Middle East.

However, according to Ole Hansen at Saxo Bank, the market continued to see limited risks of a broader conflict hitting oil supplies from the region, Dow Jones Newswires reported.

Hansen pointed to the decline in Brent crude oil futures to back up his argument.

For analysts at ING on the other hand, such geopolitical concerns were being outweighed by worries about the outlook for growth in China.

Hence in part the renewed weakness in shares of Burberry.

But it was Personal Care that was faring worst, after a jury handed down a sentence against Abbott Laboratories' specialised formula for premature infants, having found that it provoked a dangerous bowel disease in an Illinois girl.

J.P.Morgan predicted that similar cases would be settled for $150-300,000, resulting in a total settlement of $500m-1.5bn.

About 1,000 cases had been filed against Abbott, Reckitt or both in federal US or state courts.

Top performing sectors so far today

Tobacco 31,631.36 +1.47%

Real Estate Investment Trusts 2,361.69 +1.38%

Pharmaceuticals & Biotechnology 23,074.29 +1.35%

Life Insurance 5,763.93 +1.27%

Household Goods & Home Construction 14,745.46 +1.21%

Bottom performing sectors so far today

Personal Care, Drug and Grocery Stores 4,383.51 -1.17%

Travel & Leisure 7,351.58 -1.11%

Personal Goods 12,015.33 -1.02%

Construction & Materials 11,825.73 -0.95%

Automobiles & Parts 1,075.51 -0.80%

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Reckitt Benckiser Market Data

Currency UK Pounds
Share Price 4,859.00p
Change Today 26.00p
% Change 0.54 %
52 Week High 5,872.00p
52 Week Low 4,093.00p
Volume 469,238
Shares Issued 686.62m
Market Cap £33,363m

Reckitt Benckiser Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
8.25% above the market average8.25% above the market average8.25% above the market average8.25% above the market average8.25% above the market average
52.38% below the sector average52.38% below the sector average52.38% below the sector average52.38% below the sector average52.38% below the sector average
Price Trend
7.31% above the market average7.31% above the market average7.31% above the market average7.31% above the market average7.31% above the market average
13.04% above the sector average13.04% above the sector average13.04% above the sector average13.04% above the sector average13.04% above the sector average
Income
41.38% above the market average41.38% above the market average41.38% above the market average41.38% above the market average41.38% above the market average
25% below the sector average25% below the sector average25% below the sector average25% below the sector average25% below the sector average
Growth
42.03% above the market average42.03% above the market average42.03% above the market average42.03% above the market average42.03% above the market average
42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average

What The Brokers Say

Strong Buy 4
Buy 4
Neutral 9
Sell 0
Strong Sell 1
Total 18
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Reckitt Benckiser Dividends

  Latest Previous
  Interim Final
Ex-Div 01-Aug-24 11-Apr-24
Paid 13-Sep-24 24-May-24
Amount 80.40p 115.90p

Trades for 02-Jan-2025

Time Volume / Share Price
15:36 0 @ 4,884.00p
15:49 0 @ 4,886.00p
15:22 0 @ 4,878.00p
16:47 5,212 @ 4,858.61p
16:38 2 @ 4,859.00p

Reckitt Benckiser Key Personnel

Chair Jeremy Darroch
CEO Kris Licht

Top of Page